ATE412656T1 - Bicyclische heterocyclen als hiv-integrase- inhibitoren - Google Patents

Bicyclische heterocyclen als hiv-integrase- inhibitoren

Info

Publication number
ATE412656T1
ATE412656T1 AT05750075T AT05750075T ATE412656T1 AT E412656 T1 ATE412656 T1 AT E412656T1 AT 05750075 T AT05750075 T AT 05750075T AT 05750075 T AT05750075 T AT 05750075T AT E412656 T1 ATE412656 T1 AT E412656T1
Authority
AT
Austria
Prior art keywords
hiv integrase
integrase inhibitors
bicyclic heterocycles
heterocycles
bicyclic
Prior art date
Application number
AT05750075T
Other languages
English (en)
Inventor
B Narasimhulu Naidu
Jacques Banville
Francis Beaulieu
Timothy P Connolly
Mark R Krystal
John D Matiskella
Carl Ouellet
Serge Plamondon
Roger Remillard
Margaret E Sorenson
Yasutsugu Ueda
Michael A Walker
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE412656T1 publication Critical patent/ATE412656T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05750075T 2004-05-28 2005-05-12 Bicyclische heterocyclen als hiv-integrase- inhibitoren ATE412656T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57551304P 2004-05-28 2004-05-28
US60337104P 2004-08-20 2004-08-20
US11/126,891 US7176196B2 (en) 2004-05-28 2005-05-11 Bicyclic heterocycles as HIV integrase inhibitors

Publications (1)

Publication Number Publication Date
ATE412656T1 true ATE412656T1 (de) 2008-11-15

Family

ID=35456854

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05750075T ATE412656T1 (de) 2004-05-28 2005-05-12 Bicyclische heterocyclen als hiv-integrase- inhibitoren

Country Status (27)

Country Link
US (2) US7176196B2 (de)
EP (1) EP1749011B1 (de)
JP (1) JP4874959B2 (de)
KR (1) KR101097623B1 (de)
AR (1) AR049124A1 (de)
AT (1) ATE412656T1 (de)
AU (1) AU2005250356C1 (de)
BR (1) BRPI0511623A (de)
CA (1) CA2568356C (de)
CY (1) CY1110266T1 (de)
DE (1) DE602005010690D1 (de)
DK (1) DK1749011T3 (de)
ES (1) ES2315875T3 (de)
HK (1) HK1107343A1 (de)
HR (1) HRP20090005T3 (de)
IL (1) IL179455A (de)
MX (1) MXPA06013835A (de)
NO (1) NO20065879L (de)
NZ (1) NZ551282A (de)
PE (1) PE20060242A1 (de)
PL (1) PL1749011T3 (de)
PT (1) PT1749011E (de)
RS (1) RS50700B (de)
RU (1) RU2381228C2 (de)
SI (1) SI1749011T1 (de)
TW (1) TWI366567B (de)
WO (1) WO2005118593A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115601B2 (en) 2004-05-18 2006-10-03 Bristol-Myers Squibb Company HIV integrase inhibitors
US7981879B2 (en) * 2005-03-31 2011-07-19 Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. HIV integrase inhibitors
US7494984B2 (en) * 2005-08-31 2009-02-24 Bristol-Myers Squibb Company Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors
AU2006299042B8 (en) * 2005-10-04 2011-09-15 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa HIV integrase inhibitors
US7902182B2 (en) * 2005-11-16 2011-03-08 Bristol-Myers Squibb Company HIV integrase inhibitors
WO2007064316A1 (en) * 2005-11-30 2007-06-07 Bristol-Myers Squibb Company Bicyclic heterocycles as hiv integrase inhibitors
US20070129379A1 (en) * 2005-12-01 2007-06-07 Bristol-Myers Squibb Company Hiv integrase inhibitors
WO2007064502A1 (en) * 2005-12-01 2007-06-07 Bristol-Myers Squibb Company Forms of n-[(4-fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide
WO2007143446A1 (en) * 2006-05-30 2007-12-13 Bristol-Myers Squibb Company Spiro-condensed heterotricyclic compounds as hiv integrase inhibitors
US7893055B2 (en) * 2006-06-28 2011-02-22 Bristol-Myers Squibb Company HIV integrase inhibitors
EP2046328A4 (de) * 2006-07-19 2009-10-28 Univ Georgia Res Found Pyridinon-diketosäuren: hemmer der hiv-replikation bei einer kombinationstherapie
US7763630B2 (en) * 2007-06-06 2010-07-27 Bristol-Myers Squibb Company HIV integrase inhibitors
US8129398B2 (en) * 2008-03-19 2012-03-06 Bristol-Myers Squibb Company HIV integrase inhibitors
WO2009120841A1 (en) * 2008-03-27 2009-10-01 Bristol-Myers Squibb Company Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate
CA2738814C (en) * 2008-10-06 2014-01-28 Merck Sharp & Dohme Corp. Hiv integrase inhibitors
US8143244B2 (en) * 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
CN102574854B (zh) 2009-10-13 2014-04-16 伊兰科动物健康爱尔兰有限公司 大环整合酶抑制剂
US8383639B2 (en) 2009-10-15 2013-02-26 Bristol-Myers Squibb Company HIV integrase inhibitors
JP2013512957A (ja) 2009-12-07 2013-04-18 ユニバーシティ オブ ジョージア リサーチ ファウンデーション， インコーポレーテッド ピリジノンヒドロキシシクロペンチルカルボキサミド類：治療用途を備えたｈｉｖインテグラーゼ阻害剤
CA3003988C (en) 2010-01-27 2020-01-07 Viiv Healthcare Company Combinations for use in the inhibition of hiv-1
EP2552923B1 (de) 2010-04-02 2014-03-26 Janssen R&D Ireland Makrocyclische integraseinhibitoren
BR112013000925A2 (pt) 2010-07-15 2020-12-01 Bayer Intellectual Property Gmbh compostos heterocíclicos como pesticidas
US8791108B2 (en) 2011-08-18 2014-07-29 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
EP3750544A3 (de) 2011-11-30 2021-03-24 Emory University Jak-hemmer zur vorbeugung oder behandlung der viralen infektion
EP2807149A2 (de) * 2012-01-26 2014-12-03 CRO Consulting Limited Mittel zur behandlung von neurodegenerativen erkrankungen
WO2014099586A1 (en) 2012-12-17 2014-06-26 Merck Sharp & Dohme Corp. 4-pyridinonetriazine derivatives as hiv integrase inhibitors
EP2986291B1 (de) 2013-04-16 2020-05-27 Merck Sharp & Dohme Corp. 4-pyridonderivatverbindungen und verwendungen davon als hiv-integrase-hemmer
RS56701B1 (sr) 2013-05-17 2018-03-30 Merck Sharp & Dohme Fuzionisana triciklična heterociklična jedinjenja kao inhibitori hiv integraze
EP3008044B1 (de) 2013-06-13 2018-11-21 Merck Sharp & Dohme Corp. Kondensierte tricyclische heterocyclische verbindungen als hiv-integrase-hemmer
KR101809392B1 (ko) 2013-09-27 2017-12-14 머크 샤프 앤드 돔 코포레이션 Hiv 인테그라제 억제제로서 유용한 치환된 퀴놀리진 유도체
WO2016187788A1 (en) 2015-05-25 2016-12-01 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds useful for treating hiv infection
US10548910B2 (en) 2015-11-17 2020-02-04 Merck Sharp & Dohme Corp. Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors
US10544155B2 (en) 2015-12-15 2020-01-28 Merck Sharp & Dohme Corp. Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors
WO2017113288A1 (en) 2015-12-31 2017-07-06 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
CN110062627A (zh) 2016-12-02 2019-07-26 默沙东公司 可用作hiv整合酶抑制剂的三环杂环化合物
JOP20190130A1 (ar) 2016-12-02 2019-06-02 Merck Sharp & Dohme مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
WO2018140368A1 (en) 2017-01-26 2018-08-02 Merck Sharp & Dohme Corp. Substituted quinolizine derivatives useful as hiv integrase inhibitors
WO2021050555A1 (en) * 2019-09-10 2021-03-18 X-Chem, Inc. Compositions and uses thereof
CN113912622B (zh) * 2020-07-10 2023-12-01 上海纽思克生物科技有限公司 三环嘧啶酮类化合物、其制备方法、其组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1441734E (pt) 2001-10-26 2007-05-31 Isti Di Ric Di Bio Moleco P An Di-hidroxipirimidinocarboxamidas inibidoras da integrase do vih
ES2258668T3 (es) 2001-10-26 2006-09-01 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Hidroxipirimidina carboxamidas n-sustituidas inhibidoras de hiv integrasa.
US7094783B2 (en) 2002-06-26 2006-08-22 Bristol-Myers Squibb Company Bicyclic pyrimidinones as coagulation cascade inhibitors
EP1578748B1 (de) 2002-12-27 2010-09-15 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Tetrahydro-4h-pyrido[1,2-a]pyrimidine und verwandte verbindungen verwendbar als hiv integrase hemmer
AR046938A1 (es) 2003-12-12 2006-01-04 Merck & Co Inc Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
TW200526635A (en) 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
BRPI0518741A2 (pt) 2004-12-03 2008-12-02 Merck & Co Inc uso de uma combinaÇço de uma droga diretamente metabolizada por ugt1a1 ou um seu sal farmaceuticamente aceitÁvel e atazanavir ou um seu sal farmaceuticamente aceitÁvel, e, combinaÇço farmacÊutica para administraÇço oral a um mamÍfero
US7981879B2 (en) 2005-03-31 2011-07-19 Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. HIV integrase inhibitors

Also Published As

Publication number Publication date
PL1749011T3 (pl) 2009-04-30
IL179455A0 (en) 2007-05-15
US20050267105A1 (en) 2005-12-01
KR20070039502A (ko) 2007-04-12
MXPA06013835A (es) 2007-02-02
NO20065879L (no) 2007-02-20
WO2005118593A1 (en) 2005-12-15
EP1749011B1 (de) 2008-10-29
KR101097623B1 (ko) 2011-12-22
PT1749011E (pt) 2008-11-27
US20060276466A1 (en) 2006-12-07
AU2005250356C1 (en) 2011-10-06
US7511037B2 (en) 2009-03-31
BRPI0511623A (pt) 2008-03-11
AU2005250356B2 (en) 2011-03-17
CY1110266T1 (el) 2015-01-14
CA2568356C (en) 2012-07-03
SI1749011T1 (sl) 2009-08-31
HRP20090005T3 (en) 2009-02-28
RS50700B (sr) 2010-06-30
TW200600503A (en) 2006-01-01
PE20060242A1 (es) 2006-03-31
EP1749011A1 (de) 2007-02-07
JP4874959B2 (ja) 2012-02-15
AU2005250356A1 (en) 2005-12-15
HK1107343A1 (en) 2008-04-03
RU2006146970A (ru) 2008-07-10
JP2008501018A (ja) 2008-01-17
US7176196B2 (en) 2007-02-13
IL179455A (en) 2011-10-31
DE602005010690D1 (de) 2008-12-11
AR049124A1 (es) 2006-06-28
NZ551282A (en) 2009-05-31
RU2381228C2 (ru) 2010-02-10
TWI366567B (en) 2012-06-21
ES2315875T3 (es) 2009-04-01
DK1749011T3 (da) 2009-02-16
CA2568356A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
ATE412656T1 (de) Bicyclische heterocyclen als hiv-integrase- inhibitoren
EP1753767A4 (de) Bicyclische heterocyclen als hiv-integrase-inhibitoren
EP1749008A4 (de) Bicyclische heterocyclen als hiv-integrase-inhibitoren
ATE461202T1 (de) Hiv-integrasehemmer
NO20064555L (no) HIV-integraseinhibitorer.
ATE524467T1 (de) Neuartige aza-heterozyklen als kinase-inhibitoren
ATE405570T1 (de) Hiv-integrase-inhibitoren: cyclische pyrimidinonverbindung
ATE400271T1 (de) Aryl-pyridinderivate als 11-beta-hsd1-hemmer
ATE420076T1 (de) Indozolonderivate als 11b-hsd1-inhibitoren
ATE531705T1 (de) Substituierte 2-chinolyloxazole geeignet als pde4 inhibitoren
EP1725535A4 (de) Hiv-integrasehemmer
EP1756069A4 (de) Hiv-integrasehemmer
IL177189A0 (en) Hiv integrase inhibitors
ATE529421T1 (de) Chinolinderivate als phosphodiesterase-hemmer
EP1725102A4 (de) Hiv-integrasehemmer
NL2000397C2 (nl) Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
DK1962830T3 (da) Azaindolhæmmere af aurorakinaser.
ATE437876T1 (de) Hexahydropyridoisochinoline als dpp-iv- inhibitoren
ATE415400T1 (de) Pyrazolopyridinderivate
ATE509011T1 (de) Pyrimidinderivate als 11beta-hsd1-inhibitoren
EP1756114A4 (de) Hiv-integrasehemmer
EP1758585A4 (de) Hiv-integrasehemmer
DE602005002612D1 (de) Werkzeugrevolver
ATE462688T1 (de) Diarylsulfone als 5-ht2a-antagonisten
ATE435865T1 (de) Als pde5-inhibitoren verwendete pyrazoloä4,3- düpyrimidin-5-ylderivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1749011

Country of ref document: EP